Methotrexate Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-122

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 63323-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Met17 0001 01

FDA Label Image

Met17 0001 02

FDA Label Image

Met17 0001 03

Met17 0001 03
Methotrexate for Injection, USP is an anti-cancer medication that comes in vials containing 1 gram of the drug. It is free of preservatives and categorized as cytotoxic. The rest of the text contains errors and non-English characters, so it is not available.*
FDA Label Image

Met17 0001 04

Met17 0001 04
Methotrexate for Injection is a cytotoxic agent available in a 1 gram per vial dosage. It does not contain any preservative. It is for prescription use only and should be administered through routes as mentioned in the package insert. The product appears to be manufactured by Fresenius Kabi.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.